Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4516 (miR-4516) is a small, endogenous non-coding RNA (approximately 20-24 nucleotides) that acts as a post-transcriptional regulator of gene expression by binding to the 3'-untranslated regions of target messenger RNAs, leading to repression of translation or mRNA degradation. MiR-4516 has been implicated in regulating cellular processes such as cell proliferation, apoptosis, EMT, autophagy, and motility. It directly targets genes involved in stress response, cancer cell migration/invasion (e.g., OTX1 in pancreatic and retinal pigment epithelial cells, PTPN14 in glioblastoma), and ribosome function (e.g., RPL37, UBA52). MiR-4516 expression levels serve as a biomarker for prognosis in certain cancers and may also indicate environmental exposure to air pollutants. It is part of the broader microRNA family and does not encode a protein[1][2][3][4].
No conventional mechanism of action for drugs since miR-4516 is a regulatory RNA, not a protein; experimentally, mechanisms involve miRNA mimic or inhibition, leading to altered expression of its targets such as PTPN14 and OTX1[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4516 (miR-4516).